History 1 페이지
본문 바로가기
BOOKMAR
HOME
NEWS
SITEMAP
주메뉴입니다.
INTRODUCTION
Vision&Mission
Core Value & Strategy
The Future
History
Organization Chart
Location
PRODUCTS
Swine Mycoplasma Vaccine
Porcine Circovirus Vaccine
Zika Virus Vaccine
R&D
R&D Pipeline
Core Technology of R&D
NOTICE
News
Recruitment
Q&A
KOR
ENG
INTRODUCTION
Global vaccine development company creating new value for our customers by applying a variety of innovative technologies
HOME
INTRODUCTION
History
INTRODUCTION
History
Vision&Mission
Core Value & Strategy
The Future
History
Organization Chart
Location
History
2021
01
Approved for domestic clinical trials of InnoMyco vaccine
2020
12
Selected as a development project for Zika virus vaccine
05
Selected as a research project for the start-up leap package
03
Authorized the permission to export the swine Mycoplasma vaccine
02
Applied for an item permit for the swine Mycoplasma vaccine in Vietnam
2019
12
Patent granted for Swine Mycoplasma bivalent vaccines(USA)
12
Patent application filed for Zika virus vaccine
09
Established an affiliated research institute
08
Receipt of Series A investment
08
Selected as a TIPS project by the Ministry of SMEs & Startups
08
Patent application filed for Swine Mycoplasma bivalent vaccine (USA)
04
Patent application filed for Porcine Circovirus vaccine
02
Receipt of Pre-series investment
2018
07
Registered as a Venture Company
07
Implementation of U-Tech
04
Patent granted for Swine Mycoplasma bivalent vaccines(Korea)
2017
08
Finalized a patent application for Swine Mycoplasma bivalent vaccines
2016
05
Company name changed to 'Innovac'
03
'Beeson Bio Lab' founded